Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever, cytopenia and hepatitis.This infection was initially described in United States. In Europe, its epidemiology is not well known. Some isolated cases have been diagnosed in several country, were the tick Ixodes ricinus is known to transmitted another infection :the Lyme borreliosis.The purpose of our study is to look systematically for Anaplasmosis, in patient living in Eastern France, and presenting with compatible clinical symptoms using a new diagnosis tool : PCR in blood samples. So we will have new data about epidemiology in our country and the clinical symptoms that are associated with Anaplasmosis.
Study Type
OBSERVATIONAL
Enrollment
300
* Anaplasma diagnosis test : serology and PCR * If presence of Anaplasma infection, proposition of treatment with doxycylin 200 mg once-a-day during 10 days
Service des Maladies Infectieuses et Tropicales - CHU de Besançon
Besançon, France
NOT_YET_RECRUITINGCentre Hospitalier de Colmar
Colmar, France
RECRUITINGDépartement d'Infectiologie CHU de Dijon
Dijon, France
NOT_YET_RECRUITINGCentre Hospitalier de Guebwiller
Guebwiller, France
RECRUITINGCentre Hospitalier de Haguenau
Haguenau, France
RECRUITINGCentre Hospitalier de Mulhouse
Mulhouse, France
RECRUITINGService des Maladies Infectieuses et Tropicales - CHU de Nancy
Nancy, France
NOT_YET_RECRUITINGService de Médecine Interne et Maladies Infectieuses - CHU de Reims
Reims, France
RECRUITINGCentre Hospitalier de Saverne
Saverne, France
RECRUITINGCentre Hospitalier de Sélestat
Sélestat, France
RECRUITING...and 2 more locations
Risk factor, clinical and biological markers of infection for patients with Anaplasma antibody seroconversion
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.